Abstract
Myosin-6 is an actin-based motor protein that moves its cargo towards the minus-end of actin filaments. Mutations in the gene encoding the myosin-6 heavy chain and changes in the cellular abundance of the protein have been linked to hypertrophic cardiomyopathy, neurodegenerative diseases, and cancer. Here, we present a detailed kinetic characterization of the human myosin-6 motor domain, describe the effect of 2,4,6-triiodophenol on the interaction of myosin-6 with F-actin and nucleotides, and show how addition of the drug reduces the number of myosin-6-dependent vesicle fusion events at the plasma membrane during constitutive secretion.
Copyright © 2012 Federation of European Biochemical Societies. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Actins / metabolism
-
Amino-Acid N-Acetyltransferase
-
Animals
-
Gene Knockdown Techniques
-
HeLa Cells
-
Humans
-
In Vitro Techniques
-
Kinetics
-
Models, Biological
-
Models, Molecular
-
Molecular Motor Proteins / antagonists & inhibitors
-
Molecular Motor Proteins / chemistry
-
Molecular Motor Proteins / genetics
-
Molecular Motor Proteins / metabolism
-
Mutagenesis, Site-Directed
-
Myosin Heavy Chains / antagonists & inhibitors*
-
Myosin Heavy Chains / chemistry
-
Myosin Heavy Chains / genetics
-
Myosin Heavy Chains / metabolism*
-
Phenols / pharmacology
-
Protein Interaction Domains and Motifs
-
RNA, Small Interfering / genetics
-
Rabbits
-
Recombinant Fusion Proteins / antagonists & inhibitors
-
Recombinant Fusion Proteins / chemistry
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / metabolism
Substances
-
Actins
-
Molecular Motor Proteins
-
Phenols
-
RNA, Small Interfering
-
Recombinant Fusion Proteins
-
myosin VI
-
2,4,6-triiodophenol
-
Amino-Acid N-Acetyltransferase
-
Myosin Heavy Chains